当前位置:首页 - 行情中心 - 华东医药(000963) - 财务分析 - 现金流量表

华东医药

(000963)

  

流通市值:720.05亿  总市值:720.93亿
流通股本:17.52亿   总股本:17.54亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金9,882,552,619.7243,401,956,267.833,334,628,825.6321,640,152,875.03
收到的税费返还2,055,460.5511,647,283.2515,628,115.698,235,381.72
收到其他与经营活动有关的现金230,013,343.261,556,579,035.21566,037,648.66239,783,680.99
经营活动现金流入的平衡项目0000
经营活动现金流入小计10,114,621,423.5344,970,182,586.2633,916,294,589.9821,888,171,937.74
购买商品、接受劳务支付的现金7,695,820,108.3128,195,403,709.5121,947,910,270.0813,604,550,741.22
支付给职工以及为职工支付的现金1,441,219,423.874,755,191,780.743,446,050,305.282,323,118,629.52
支付的各项税费671,816,951.082,574,487,192.251,962,213,221.831,477,481,035.41
支付其他与经营活动有关的现金1,138,493,634.155,696,171,021.414,053,717,983.882,207,765,050.15
经营活动现金流出的平衡项目0000
经营活动现金流出小计10,947,350,117.4141,221,253,703.9131,409,891,781.0719,612,915,456.3
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额-832,728,693.883,748,928,882.352,506,402,808.912,275,256,481.44
二、投资活动产生的现金流量:
收回投资收到的现金-1,000,0001,000,0003,000,000
取得投资收益收到的现金43,350,00045,230,192.9845,200,00027,900,000
处置固定资产、无形资产和其他长期资产收回的现金净额9,751,90719,759,145.852,528,623.356,946,255.32
收到的其他与投资活动有关的现金-261,016,721.64263,981,767.12255,959,940.22
投资活动现金流入的平衡项目0000
投资活动现金流入小计53,101,907327,006,060.47312,710,390.47293,806,195.54
购建固定资产、无形资产和其他长期资产支付的现金637,322,382.411,727,864,860.12930,485,860.82658,042,086.97
投资支付的现金61,618,92569,176,613.4152,360,852.87147,660,247.99
取得子公司及其他营业单位支付的现金-461,958,981.61348,814,981.61-
支付其他与投资活动有关的现金-238,277,274.34485,504,341.65157,607,933.95
投资活动现金流出的平衡项目0000
投资活动现金流出小计698,941,307.412,497,277,729.471,917,166,036.95963,310,268.91
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-645,839,400.41-2,170,271,669-1,604,455,646.48-669,504,073.37
三、筹资活动产生的现金流量:
取得借款收到的现金1,289,998,8484,559,775,187.363,543,115,046.172,552,138,017.63
收到其他与筹资活动有关的现金146,000,000690,739,328.24343,706,321.33291,490,536.33
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,435,998,8485,250,514,515.63,886,821,367.52,843,628,553.96
偿还债务支付的现金1,279,708,605.453,571,431,254.372,930,078,520.911,988,027,915.09
分配股利、利润或偿付利息支付的现金17,579,298.661,733,453,239.021,751,880,188.481,082,542,915.33
其中:子公司支付给少数股东的股利、利润-31,275,554.965,994,6602,760,660
支付其他与筹资活动有关的现金225,549,581.73695,294,341.33366,279,261.77260,287,332.28
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,522,837,485.846,000,178,834.725,048,237,971.163,330,858,162.7
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-86,838,637.84-749,664,319.12-1,161,416,603.66-487,229,608.74
四、汇率变动对现金及现金等价物的影响-3,115,685.5-47,001,718.4621,363,561.91-5,787,341.62
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-1,568,522,417.63781,991,175.77-238,105,879.321,112,735,457.71
加:期初现金及现金等价物余额4,990,151,186.684,208,160,010.914,208,160,010.914,208,160,010.91
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额3,421,628,769.054,990,151,186.683,970,054,131.595,320,895,468.62
补充资料:
净利润-3,494,185,631.76-1,688,215,051.04
资产减值准备-153,185,473.56-68,478,748.14
固定资产和投资性房地产折旧-473,271,554.08-274,930,992.33
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-473,271,554.08-274,930,992.33
无形资产摊销-291,077,823.5-149,210,060.05
长期待摊费用摊销-9,728,874.68-4,432,515.07
处置固定资产、无形资产和其他长期资产的损失-5,463,399.18--4,927,280.24
固定资产报废损失-2,033,665.48-567,416.71
公允价值变动损失-0--
财务费用-87,246,657.66-54,026,429.63
投资损失-82,799,888.43-23,136,255.81
递延所得税--49,278,116.87--56,325,293.76
其中:递延所得税资产减少--33,855,364.93--47,082,718.43
递延所得税负债增加--15,422,751.94--9,242,575.33
存货的减少--498,851,129.33--723,903,503.56
经营性应收项目的减少--1,979,535,459.83--1,460,081,003.94
经营性应付项目的增加-1,565,935,497.69-2,247,011,472.66
其他-20,980,024.57-10,484,621.5
现金的期末余额-4,990,151,186.68-5,320,895,468.62
减:现金的期初余额-4,208,160,010.91-4,208,160,010.91
加:现金等价物的期末余额-0--
减:现金等价物的期初余额-0--
公告日期2025-04-252025-04-182024-10-252024-08-16
审计意见(境内)标准无保留意见
TOP↑